Publication: Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI
dc.contributor.buuauthor | Sağ, Salim | |
dc.contributor.buuauthor | Yıldız, Abdülmecit | |
dc.contributor.buuauthor | Aydın, Kaderli Aysel | |
dc.contributor.buuauthor | Gül, Bülent Cuma | |
dc.contributor.buuauthor | Bedir, Ömer | |
dc.contributor.buuauthor | Ceǧilli, Ercan | |
dc.contributor.buuauthor | Özdemir, Bülent | |
dc.contributor.buuauthor | Can, Fatma Ezgi | |
dc.contributor.buuauthor | Aydınlar, Ali | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Biyoistatistik Ana Bilim Dalı | |
dc.contributor.department | Kardiyoloji Ana Bilim Dalı | |
dc.contributor.department | Nefroloji Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0002-8974-8837 | |
dc.contributor.orcid | 0000-0001-8404-8252 | |
dc.contributor.orcid | 0000-0002-1953-7735 | |
dc.contributor.researcherid | AAI-6632-2021 | |
dc.contributor.researcherid | AAW-9185-2020 | |
dc.contributor.scopusid | 12140008100 | |
dc.contributor.scopusid | 57192158999 | |
dc.contributor.scopusid | 7801322152 | |
dc.contributor.scopusid | 57140207000 | |
dc.contributor.scopusid | 57191868066 | |
dc.contributor.scopusid | 57144621700 | |
dc.contributor.scopusid | 7004168959 | |
dc.contributor.scopusid | 56689608500 | |
dc.contributor.scopusid | 57192164890 | |
dc.date.accessioned | 2022-12-28T12:39:52Z | |
dc.date.available | 2022-12-28T12:39:52Z | |
dc.date.issued | 2016-05-18 | |
dc.description.abstract | Background: Contrast induced nephropathy (CIN) has been proven to be a clinical condition related to adverse cardiovascular outcomes. In recent studies, the monocyte to high density lipoprotein ratio (MHR) has been-postulated as a novel parameter associated with adverse renal and cardiovascular outcomes. In this study we-investigated the association of MHR with CIN in-ST-segment elevation myocardial infarction (STEMI) patients treated with primary percutaneous coronary intervention (PCI). Methods: Consecutive STEMI patients treated with primary PCI were prospectively recruited. Subjects were categorized into two groups; as patients who developed CIN (CIN+) and patients who did not develop CIN (CIN-) during hospitalization. CIN was defined as either a 25% increase in serum creatinine from baseline or 44.20 mu mol/L increase in absolute value, within 72 h of intravenous contrast administration. Results: A total number of 209 patients were included in the study. Thirty-two patients developed CIN (15.3%). In the CIN (+) patients, monocytes were higher [1.02 (0.83-1.39) vs. 0.69 (0.53-0.90) 109/L, p < 0.01] and HDL cholesterol levels were lower [0.88 (0.78-1.01) vs. 0.98 (0.88-1.14) mmol/L, p < 0.01]. In addition, MHR was significantly higher in the CIN (+) group [1.16 (0.89-2.16) vs. 0.72 (0.53-0.95) 10(9)/mmol, p < 0.01]. In multivariate logistic regression analysis, MHR, Mehran score, AGEF score and CV/eGFR were independently correlated with CIN. Conclusions: Higher MHR levels may predict CIN development after primary PCI in STEMI patients. | |
dc.identifier.citation | Sağ, S. vd. (2017). ''Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI''. Clinical Chemistry and Laboratory Medicine, 55(1), 132-138. | |
dc.identifier.endpage | 138 | |
dc.identifier.issn | 1434-6621 | |
dc.identifier.issue | 1 | |
dc.identifier.pubmed | 27331308 | |
dc.identifier.scopus | 2-s2.0-84998636412 | |
dc.identifier.startpage | 132 | |
dc.identifier.uri | https://doi.org/10.1515/cclm-2016-0005 | |
dc.identifier.uri | https://www.degruyter.com/document/doi/10.1515/cclm-2016-0005/html | |
dc.identifier.uri | 1437-4331 | |
dc.identifier.uri | http://hdl.handle.net/11452/30143 | |
dc.identifier.volume | 55 | |
dc.identifier.wos | 000388930700023 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | Walter de Gruyter | |
dc.relation.journal | Clinical Chemistry and Laboratory Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Medical laboratory technology | |
dc.subject | Contrast induced nephropathy | |
dc.subject | HDL-cholesterol | |
dc.subject | Monocyte | |
dc.subject | Percutaneous coronary intervention | |
dc.subject | Acute kidney injury | |
dc.subject | High-density-lipoprotein | |
dc.subject | Elevation myocardial-infarction | |
dc.subject | Creatinine clearance ratio | |
dc.subject | Primary angioplasty | |
dc.subject | Cardiovascular events | |
dc.subject | N-acetylcysteine | |
dc.subject | Renal-function | |
dc.subject | Risk score | |
dc.subject.emtree | Acetylsalicylic acid | |
dc.subject.emtree | Clopidogrel | |
dc.subject.emtree | Creatinine | |
dc.subject.emtree | Heparin | |
dc.subject.emtree | High density lipoprotein cholesterol | |
dc.subject.emtree | Iohexol | |
dc.subject.emtree | Contrast medium | |
dc.subject.emtree | High density lipoprotein cholesterol | |
dc.subject.emtree | Adult | |
dc.subject.emtree | Aged | |
dc.subject.emtree | AGEF score | |
dc.subject.emtree | Article | |
dc.subject.emtree | Contrast induced nephropathy | |
dc.subject.emtree | Controlled study | |
dc.subject.emtree | Coronary angiography | |
dc.subject.emtree | Coronary stenting | |
dc.subject.emtree | Correlation analysis | |
dc.subject.emtree | Creatinine blood level | |
dc.subject.emtree | Estimated glomerular filtration rate | |
dc.subject.emtree | Female | |
dc.subject.emtree | Hospitalization | |
dc.subject.emtree | Human | |
dc.subject.emtree | Loading drug dose | |
dc.subject.emtree | Major clinical study | |
dc.subject.emtree | Male | |
dc.subject.emtree | Mehran score | |
dc.subject.emtree | Middle aged | |
dc.subject.emtree | Monocyte | |
dc.subject.emtree | Multivariate logistic regression analysis | |
dc.subject.emtree | Percutaneous coronary intervention | |
dc.subject.emtree | Percutaneous transluminal angioplasty | |
dc.subject.emtree | Priority journal | |
dc.subject.emtree | Prospective study | |
dc.subject.emtree | Scoring system | |
dc.subject.emtree | ST segment elevation myocardial infarction | |
dc.subject.emtree | Blood | |
dc.subject.emtree | Chemically induced | |
dc.subject.emtree | Cytology | |
dc.subject.emtree | Kidney diseases | |
dc.subject.emtree | Monocyte | |
dc.subject.emtree | Receiver operating characteristic | |
dc.subject.emtree | ST elevation myocardial infarction | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Cholesterol, HDL | |
dc.subject.mesh | Contrast media | |
dc.subject.mesh | Female | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Kidney diseases | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle aged | |
dc.subject.mesh | Monocytes | |
dc.subject.mesh | Percutaneous coronary intervention | |
dc.subject.mesh | ROC curve | |
dc.subject.mesh | ST elevation myocardial infarction | |
dc.subject.scopus | Contrast Induced Nephropathy; Coronary Angiography; Kidney Diseases | |
dc.subject.wos | Medical laboratory technology | |
dc.title | Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI | |
dc.type | Article | |
dc.wos.quartile | Q1 | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Kardiyoloji Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/Nefroloji Ana Bilim Dalı | |
local.contributor.department | Tıp Fakültesi/Biyoistatistik Ana Bilim Dalı | |
local.indexed.at | Scopus | |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: